LUNG Q2 2021 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena

LUNGPulmonx Corporation

$75M

Q2 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$12M+232.2% YoY

Gross Profit

$9M74.0% margin

Operating Income

-$13M-103.9% margin

Net Income

-$13M-106.2% margin

EPS (Diluted)

$-0.34

QoQ Revenue Growth

+32.0%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$249M

Total Liabilities

$39M

Stockholders' Equity

$210M

Cash & Equivalents

$199M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$4M	+232.2%
Gross Profit	$9M	$1M	+792.2%
Operating Income	-$13M	-$12M	-10.0%
Net Income	-$13M	-$12M	-8.8%

Geographic Segments

UNITED STATES

$7M54%

EMEA

$5M39%

Asia Pacific

$875,0007%

Other International Geographical Areas

$12,0000%